NCT06177106View on ClinicalTrials.gov

SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants

NARecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

December 31, 2027

Conditions
Other Skin Changes Due to Chronic Exposure to Nonionizing Radiation
Interventions
OTHER

Solar Simulated Light

Acute SSL will be delivered to sun damaged skin at a rate of two-times the minimal erythema dose of each individual subject. Minimal erythema dose is defined as the smallest dose of energy necessary to produce confluent erythema with four distinct borders at 22-26 hours post-exposure.

Trial Locations (1)

85719

RECRUITING

University of Arizona Cancer Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER